British American Tobacco Balances CBD Ambitions with Insider Dividend Reinvestment

British American Tobacco converts CAD 75.3M note into Charlotte's Web shares and sees director dividend reinvestment, as stock trades overbought with RSI 98.3 amid transition to smokeless.

A flurry of capital allocation moves has put British American Tobacco in the spotlight, as the group simultaneously deepens its bet on cannabinoid wellness and signals unwavering commitment to shareholder returns. The two events — a director’s dividend reinvestment worth just over £2,000 and a multi-million-dollar conversion into CBD company Charlotte’s Web — illustrate the tightrope the London-listed giant is walking between transformation and income generation.

The biggest headline came from BAT’s Canadian subsidiary, BT DE Investments, which converted an outstanding convertible note into common shares of Charlotte’s Web Holdings. The note, originally sized at CAD 75.3 million (roughly USD 55 million), plus accrued interest, was swapped for shares at CAD 0.94 apiece, bringing the total conversion value to CAD 89.6 million (USD 65 million). On top of that, the subsidiary subscribed to 14.7 million new shares via a private placement at the same price, raising USD 10 million for Charlotte’s Web to fund a planned Medicare pilot programme and other medical initiatives.

Only days earlier, BAT non-executive director Serpil Timuray and a related person, Abdurrahman Murat Timuray, acquired 47 ordinary shares through a dividend reinvestment. The transaction, executed on 26 May 2026 at £43.718739 per share, totalled £2,054.78. Unlike a discretionary market purchase, this was a mandated reinvestment of dividend income — a detail that shifts the spotlight from the director’s personal conviction to the group’s broader payout policy.

The market reaction to the CBD news was muted at best. On 29 May, BAT shares traded around EUR 52.78 in London, down 2.15% on the day. The stock has had a strong run: over the past twelve months it has climbed 36%, while another recent measure put the one-year gain at more than 33%. The RSI stands at 98.3, a level that screams overbought and suggests a near-term pullback may be overdue. Annualised volatility of 31.5% adds to the caution for short-term traders.

Yet the longer-term narrative remains anchored in the transition away from combustible cigarettes. BAT’s preliminary 2025 numbers showed New Categories revenue of £3.62 billion, up 7% on a constant-currency basis, and the smokeless segment now accounts for 18.2% of group revenue. The number of consumers of non-combustible brands rose by 4.7 million to 34.1 million. Operating profit from New Categories surged 77.1% to £442 million, while the adjusted operating margin held at 44.0%.

For 2026, management has laid out a tempered outlook: global cigarette volumes are expected to decline by around 2%, with group revenue growth landing at the lower end of the medium-term range of 3% to 5%. New Categories should expand at a low-double-digit pace. Adjusted operating profit growth is forecast at 4% to 6%, and adjusted EPS growth at 5% to 8%. The profit trajectory, management warned, will be weighted to the second half.

On the capital return side, BAT has reaffirmed a £1.3 billion share buyback for the current year, with a programme through Merrill Lynch International running until 29 June 2026. The annual general meeting authorised the repurchase of up to 217.5 million shares. The 2025 dividend was raised 2.0% to 245.04 pence per share, with the next ex-dividend date set for 24 December 2026 and payment on 3 February 2027. The group has pledged continued dividend growth in sterling.

While the Charlotte’s Web stake adds optionality in the regulated CBD and wellness space, its contribution to the bottom line remains uncertain and subject to regulatory hurdles. For now, the stock’s main drivers are execution on the guidance, the momentum in New Categories, cash generation, and the steady reduction of debt. The director’s tiny reinvestment may be symbolic, but it reinforces a payout strategy that income investors continue to rely on as the transformation unfolds.